Turski
Klaus Turski, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20160080168 | CAN FD - A device for allowing a CAN 2.0B controller to participate passively in CAN FD communication is described. The device is configured to identify whether a frame on RXD is a CAN FD frame and, in dependence upon identifying that the frame is a CAN FD frame, to replace a section of the CAN FD frame, including the data phase of the CAN FD frame, with substitute data having a format which complies with CAN 2.0B. The device may be included in a CAN transceiver. | 03-17-2016 |
Lechoslaw A. Turski, Weesp NL
Patent application number | Description | Published |
---|---|---|
20090005395 | SILDENAFIL N-OXIDE AS PRODRUG - Embodiments of the present invention relate to a compound of formula (1 | 01-01-2009 |
20090005455 | N-OXIDES OF VENLAFAXINE AND O-DESMETHYLVENLAFAXINE AS PRODRUGS - Embodiments of the invention relate to a compound of formula (1), | 01-01-2009 |
Mark Turski, Manchester GB
Patent application number | Description | Published |
---|---|---|
20160024619 | CORRODIBLE DOWNHOLE ARTICLE - A magnesium alloy suitable for use as a corrodible downhole article. The alloy has a corrosion rate of at least 50 mg/cm | 01-28-2016 |
Michelle Turski, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20150347699 | Actionability framework for genomic biomarker - An evidence-based computerized method for forming treatment plans can utilize an actionability framework, which can include a basis of actionability and a rationale for actionability for biomarkers. Treatment rules derived from data in literature, such as from clinical trials, case studies, research and published literature, can allow the method to form treatment plans with support reasoning and citations, similar to those of medical professionals. Thus the treatment plans proposed by the evidence-based treatment process can survive the inspection and scrutiny of treating physicians due to the available and cited support documents. | 12-03-2015 |
Michelle L. L. Turski, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20150017261 | Methods of Treating and Preventing Cancer by Disrupting the Binding of Copper in the Map Kinase Pathway - The present disclosure provides methods of treating and/or preventing cancer in a subject comprising administering to the subject a copper-reduced diet by itself or as a supplement along with a regular diet to create a copper-reduced melieu, maintain a reduced-copper melieu, or both, thereby treating and/or preventing the development of the cancer. Methods also comprise further adding a copper chelator, MEK inhibitor, or combinations thereof. | 01-15-2015 |